Shasha Rao

1.8k total citations
37 papers, 1.5k citations indexed

About

Shasha Rao is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Shasha Rao has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Shasha Rao's work include Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (15 papers) and Drug Transport and Resistance Mechanisms (7 papers). Shasha Rao is often cited by papers focused on Drug Solubulity and Delivery Systems (17 papers), Advanced Drug Delivery Systems (15 papers) and Drug Transport and Resistance Mechanisms (7 papers). Shasha Rao collaborates with scholars based in Australia, China and Denmark. Shasha Rao's co-authors include Clive A. Prestidge, Angel Tan, Vaskor Bala, Nicky Thomas, Ben J. Boyd, Tahnee J. Dening, Nicolas H. Voelcker, Terrance G. Johns, Gordon McPhee and Benjamin Thierry and has published in prestigious journals such as Nature Communications, PLoS ONE and ACS Applied Materials & Interfaces.

In The Last Decade

Shasha Rao

36 papers receiving 1.5k citations

Peers

Countries citing papers authored by Shasha Rao

Since Specialization

Citations

This map shows the geographic impact of Shasha Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shasha Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shasha Rao more than expected).

Fields of papers citing papers by Shasha Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shasha Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shasha Rao. The network helps show where Shasha Rao may publish in the future.

Co-authorship network of co-authors of Shasha Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Shasha Rao. A scholar is included among the top collaborators of Shasha Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shasha Rao. Shasha Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and characterization of bio-based maltitol modified polybutylene terephthalate 2025 ·Materials Today Communications ·(unknown), Wenxuan Zhang, (unknown), Wensheng Wang, (unknown), Zhichao He, Tong Liu, Yang Qiao, Shasha Rao, Lv Jinlong	0
2	Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi 2018 ·Murdoch Research Repository (Murdoch University) ·Gavin J. Partridge, Shasha Rao, (unknown), (unknown), Alan J. Lymbery, Clive A. Prestidge	1
3	Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi 2018 ·Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology ·Gavin J. Partridge, Shasha Rao, (unknown), (unknown), Alan J. Lymbery, Clive A. Prestidge	12
4	Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Hayley B. Schultz, Nicky Thomas, Shasha Rao, Clive A. Prestidge	40
5	Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies 2017 ·International Journal of Pharmaceutics ·Tahnee J. Dening, Shasha Rao, Nicky Thomas, Clive A. Prestidge	24
6	Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis 2016 ·The Journal of Antibiotics ·Shasha Rao, Clive A. Prestidge, Lynn Miesel, (unknown), Dean L. Shinabarger, Ramiz A. Boulos	19
7	Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs 2016 ·European Journal of Pharmaceutical Sciences ·(unknown), Shasha Rao, Kristen E. Bremmell, Clive A. Prestidge	15
8	Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems 2015 ·The AAPS Journal ·Tahnee J. Dening, Shasha Rao, Nicky Thomas, Clive A. Prestidge	54
9	Oral nanomedicine approaches for the treatment of psychiatric illnesses 2015 ·Journal of Controlled Release ·Tahnee J. Dening, Shasha Rao, Nicky Thomas, Clive A. Prestidge	41
10	An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm–associated rhinosinusitis 2015 ·Translational research ·Camille Jardeleza, Benjamin Thierry, Shasha Rao, (unknown), Amanda Drilling, Dijana Miljkovic, Sathish Paramasivan, Craig James, Dong Dong, Nicky Thomas, Sarah Vreugde, Clive A. Prestidge, Peter‐John Wormald	26
11	Impact of Solidification on the Performance of Lipid-based Colloidal Carriers: Oil-based versus Self-emulsifying Systems 2015 ·Current Drug Delivery ·(unknown), Angel Tan, Shasha Rao, Clive A. Prestidge	12
12	Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation 2015 ·Journal of Molecular Graphics and Modelling ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shasha Rao, D. Ramachandran	5
13	Lipophilic Prodrugs of SN38: Synthesis and in Vitro Characterization toward Oral Chemotherapy 2015 ·Molecular Pharmaceutics ·Vaskor Bala, Shasha Rao, Peng Li, Shudong Wang, Clive A. Prestidge	59
14	Liposome-Encapsulated ISMN: A Novel Nitric Oxide-Based Therapeutic Agent against Staphylococcus aureus Biofilms 2014 ·PLoS ONE ·Camille Jardeleza, Shasha Rao, Benjamin Thierry, (unknown), Sarah Vreugde, Clive A. Prestidge, Peter‐John Wormald	36
15	First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen 2013 ·Drug Delivery and Translational Research ·Angel Tan, Nasrin Ghouchi Eskandar, Shasha Rao, Clive A. Prestidge	65
16	Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38 2013 ·Journal of Controlled Release ·Vaskor Bala, Shasha Rao, Ben J. Boyd, Clive A. Prestidge	167
17	Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance 2013 ·Pharmaceutical Research ·Angel Tan, Shasha Rao, Clive A. Prestidge	138
18	The effect of isosteviol on hyperglycemia and dyslipidemia induced by lipotoxicity in rats fed with high-fat emulsion 2011 ·Life Sciences ·(unknown), Min Xu, Lin Lin, Shasha Rao, Jiping Wang, Andrew K. Davey	31
19	Recent Advances in the Research and Development of B-Raf Inhibitors 2010 ·Current Medicinal Chemistry ·Huifang Li, Yadong Chen, Shasha Rao, Xiu‐Mei Chen, (unknown), (unknown), (unknown), (unknown), Xiang Zhou, Tao Lu	25
20	Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas 2008 ·European Journal of Medicinal Chemistry ·Huifang Li, Tao Lu, Tian Zhu, (unknown), Shasha Rao, Liye Hu, Bo‐Tao Xin, Yadong Chen	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact